Top View
- Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients Erin R
- Molecular Basis of Disease Cytochrome P450s in Humans Feb
- Effects of Metformin on Cytochromes CYP3А, CYP2С and CYP2Е1 Functioning at Metabolic Syndrome in Rats of Different Age
- INSPRA® (Eplerenone) Tablets, for Oral Use Initial U.S
- Pharmacogenomics of Hypertension Treatment
- Human Steroid Biosynthesis, Metabolism and Excretion
- Functional Polymorphisms in the CYP3A4, CYP3A5, and CYP21A2 Genes in the Risk for Hypertension in Pregnancy
- Heterogeneity of CYP3A Isoforms Metabolizing Erythromycin and Cortisol
- Epigallocatechin Gallate Modulates CYP450 Isoforms in the Female Swiss-Webster Mouse
- Association of Genotypes of the CYP3A Cluster with Midazolam Disposition in Vivo
- Induction-Liver-Intestinal-Cytochrome-P450-CYP-Enzymes-Cynomolgus-Monkeys.Pdf
- VERZENIO™ (Abemaciclib) Tablets, for Oral Use Antidiarrheal Therapy, Increase Oral Fluids, and Notify Their Initial U.S
- Cell Foundry with High Product Specificity and Catalytic Activity For
- Physiologic Effects of Cytochrome P450 3A Activity
- Table of Substrates, Inhibitors and Inducers
- Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism
- FDA Guidance for Industry
- CYP3A4 Mutation Causes Vitamin D–Dependent Rickets Type 3
- Studies on 4Β-Hydroxycholesterol, a Marker of Cyp3a Activity, and Its Association with 25-Hydroxyvitamin D
- In the Liver of Mouse Induced by Microcystin-LR
- Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants
- RAYALDEE (Calcifediol) Extended-Release Capsules, for Oral Use About the Symptoms of Elevated Calcium
- Steroid Pathways Spironolactone84, Dexamethasone85, Adrenal Gland (+) 86 84 87 Ketoconazole29, Bile Acid , St
- A Review of the Important Role of CYP2D6 in Pharmacogenomics
- (CYP3A) in Brushtail Possums (Trichosurus Vulpecula) Exposed to Eucalyptus Terpenes ⁎ Jennifer S
- Managing the Risk of CYP3A Induction in Drug Development: a Strategic Approach S
- Highly Selective Inhibition of Human Cyp3a in Vitro by Azamulin and Evidence That Inhibition Is Irreversible
- Plasma Letrozole Concentrations in Postmenopausal Women with Breast Cancer Are Associated with CYP2A6 Genetic Variants, Body Mass Index, and Age
- Understanding Aromatase: a Mechanistic Basis For
- Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on The
- Human Lanosterol 14-Alpha Demethylase (CYP51A1) Is a Putative Target for Natural Flavonoid Luteolin 7,30-Disulfate
- Bile Acids, Nuclear Receptors and Cytochrome P450
- The Good and the Bad of Vitamin D Inactivation
- Alternative Splicing in the Cytochrome P450 Superfamily Expands Protein Diversity to Augment Gene Function and Redirect Human Drug Metabolism S
- Identification of the Fetal Liver Cytochrome CYP3A7 in Human Endometrium and Placenta
- The Use of Aromatase Inhibitors in Boys with Short
- Role of Human Cytochrome P450 3A4 in Metabolism of Medroxyprogesterone Acetate
- CYP3A5 Polymorphism, Amlodipine and Hypertension
- DRUG INTERACTIONS with CYP3A INDUCERS and INHIBITORS for TORISEL® (Temsirolimus) Injection
- Drug Interaction Potential of Osilodrostat (LCI699) Based on Its Effect on the Pharmacokinetics of Probe Drugs of Cytochrome P450 Enzymes in Healthy Adults
- Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice S
- The Influence of Biological Sex and Sex Hormones on Bile Acid
- CYP2D6 Is Inducible by Endogenous and Exogenous Corticosteroids
- Drug-Drug and Food-Drug Interactions
- Vitamin D: Newer Concepts of Its Metabolism and Function at the Basic and Clinical Level
- Alternative Splicing in the Cytochrome P450 Superfamily Expands Protein Diversity to Augment Gene Function and Redirect Human Drug Metabolism S